These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 32191995)

  • 1. Suramin Inhibits Chikungunya Virus Replication by Interacting with Virions and Blocking the Early Steps of Infection.
    Albulescu IC; White-Scholten L; Tas A; Hoornweg TE; Ferla S; Kovacikova K; Smit JM; Brancale A; Snijder EJ; van Hemert MJ
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32191995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Chikungunya Virus Monoclonal Antibody That Inhibits Viral Fusion and Release.
    Tumkosit U; Siripanyaphinyo U; Takeda N; Tsuji M; Maeda Y; Ruchusatsawat K; Shioda T; Mizushima H; Chetanachan P; Wongjaroen P; Matsuura Y; Tatsumi M; Tanaka A
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization.
    Silva LA; Khomandiak S; Ashbrook AW; Weller R; Heise MT; Morrison TE; Dermody TS
    J Virol; 2014 Mar; 88(5):2385-97. PubMed ID: 24371059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry.
    Henß L; Beck S; Weidner T; Biedenkopf N; Sliva K; Weber C; Becker S; Schnierle BS
    Virol J; 2016 Aug; 13(1):149. PubMed ID: 27581733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway.
    Bouma EM; van de Pol DPI; Sanders ID; Rodenhuis-Zybert IA; Smit JM
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suramin Inhibits Chikungunya Virus Entry and Transmission.
    Ho YJ; Wang YM; Lu JW; Wu TY; Lin LI; Kuo SC; Lin CC
    PLoS One; 2015; 10(7):e0133511. PubMed ID: 26208101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suramin inhibits chikungunya virus replication through multiple mechanisms.
    Albulescu IC; van Hoolwerff M; Wolters LA; Bottaro E; Nastruzzi C; Yang SC; Tsay SC; Hwu JR; Snijder EJ; van Hemert MJ
    Antiviral Res; 2015 Sep; 121():39-46. PubMed ID: 26112648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suramin inhibits Zika virus replication by interfering with virus attachment and release of infectious particles.
    Albulescu IC; Kovacikova K; Tas A; Snijder EJ; van Hemert MJ
    Antiviral Res; 2017 Jul; 143():230-236. PubMed ID: 28461070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging Chikungunya Virus Variants at the E1-E1 Interglycoprotein Spike Interface Impact Virus Attachment and Inflammation.
    Rangel MV; McAllister N; Dancel-Manning K; Noval MG; Silva LA; Stapleford KA
    J Virol; 2022 Feb; 96(4):e0158621. PubMed ID: 34935436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection.
    Oo A; Rausalu K; Merits A; Higgs S; Vanlandingham D; Bakar SA; Zandi K
    Antiviral Res; 2018 Feb; 150():101-111. PubMed ID: 29269135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4'-Fluorouridine inhibits alphavirus replication and infection
    Yin P; May NA; Lello LS; Fayed A; Parks MG; Drobish AM; Wang S; Andrews M; Sticher Z; Kolykhalov AA; Natchus MG; Painter GR; Merits A; Kielian M; Morrison TE
    mBio; 2024 Jun; 15(6):e0042024. PubMed ID: 38700353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the chikungunya virus E1 glycoprotein domain II and hinge influence E2 conformation, infectivity, and virus-receptor interactions.
    Thannickal SA; Battini L; Spector SN; Noval MG; Álvarez DE; Stapleford KA
    J Virol; 2024 Jul; 98(7):e0067924. PubMed ID: 38842335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis of Chikungunya virus inhibition by monoclonal antibodies.
    Zhou QF; Fox JM; Earnest JT; Ng TS; Kim AS; Fibriansah G; Kostyuchenko VA; Shi J; Shu B; Diamond MS; Lok SM
    Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27637-27645. PubMed ID: 33087569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
    Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
    mBio; 2016 May; 7(3):. PubMed ID: 27222471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination of doxycycline and ribavirin alleviated chikungunya infection.
    Rothan HA; Bahrani H; Mohamed Z; Teoh TC; Shankar EM; Rahman NA; Yusof R
    PLoS One; 2015; 10(5):e0126360. PubMed ID: 25970853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Explorations on the antiviral potential of zinc and magnesium salts against chikungunya virus: implications for therapeutics.
    Davuluri KS; Shukla S; Kakade M; Cherian S; Alagarasu K; Parashar D
    Front Cell Infect Microbiol; 2024; 14():1335189. PubMed ID: 38895735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host oxidative folding pathways offer novel anti-chikungunya virus drug targets with broad spectrum potential.
    Langsjoen RM; Auguste AJ; Rossi SL; Roundy CM; Penate HN; Kastis M; Schnizlein MK; Le KC; Haller SL; Chen R; Watowich SJ; Weaver SC
    Antiviral Res; 2017 Jul; 143():246-251. PubMed ID: 28461071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tomatidine, a natural steroidal alkaloid shows antiviral activity towards chikungunya virus in vitro.
    Troost B; Mulder LM; Diosa-Toro M; van de Pol D; Rodenhuis-Zybert IA; Smit JM
    Sci Rep; 2020 Apr; 10(1):6364. PubMed ID: 32286447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Transmission of Antiviral Drug-Resistant Chikungunya Viruses by
    Delang L; Yen PS; Vallet T; Vazeille M; Vignuzzi M; Failloux AB
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30135220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a novel antiviral agent targeting the nonstructural protein 4 (nsP4) of chikungunya virus.
    Wada Y; Orba Y; Sasaki M; Kobayashi S; Carr MJ; Nobori H; Sato A; Hall WW; Sawa H
    Virology; 2017 May; 505():102-112. PubMed ID: 28236746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.